SEC Form 4 · accession 0001140361-15-033678
PLUS THERAPEUTICS, INC. · CNSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Rickey
Director
Period of report
Aug 26, 2015
Accepted (ET)
Aug 28, 2015 · 7:12 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001095981
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 26, 2015 | P | 25,000 | $0.327 | A | 582,385 | I | By Trust |
| Common StockF2,F1 | Aug 27, 2015 | P | 50,000 | $0.2992 | A | 632,385 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities are owned by Dave Rickey, TTEE FBO the David Rickey Trust.
- F2The shares were purchased in multiple open market transactions ranging in price from $0.297 to $0.30 per share, with a weighted average price of $0.2992 (as reported above).